MYD88 and carcinoma: CXCR3 knockdown suppresses TLR4/MyD88, BIRC, and COL1A1 expression, inhibits proliferation and migration, and promotes apoptosis, thereby attenuating cirrhosis-to-carcinoma transition (39).